1. A novel rMVA combination immunotherapy triggers potent innate and adaptive immune responses against established tumors. (March 2018) Authors: Medina, J.; Hinterberger, M.; Testori, M.; Geiger, M.; Giessel, R.; Bathke, B.; Kassub, R.; Graebnitz, F.; Fiore, G.; Chaplin, P.; Hochrein, H.; Lauterbach, H. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 1 Page Start: S24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MVA-BN as monkeypox vaccine for healthy and immunocompromised. (December 2020) Authors: Overton, E.T.; Lawrence, S.; Stapleton, J.; Weidenthaler, H.; Schmidt, D.; Nopora, K.; Meyer, T.; Maclennan, J.; Koenen, B.; Silbernagl, G.; Volkmann, A.; Chaplin, P. Journal: International journal of infectious diseases Issue: Volume 101(2020)Supplement 1 Page Start: 464 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗